EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Explainable Artificial Intelligence Unravels the Possible Distinct Roles of VKORC1 and CYP2C9 in Predicting Warfarin Anticoagulation Control

Kannan Sridharan iD, Gowri Sivaramakrishnan iD

Medical Sciences · 2026

DOI: 10.3390/medsci14010156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Sciences, 2026. Verfasst von Kannan Sridharan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, Arabian Gulf University, Manama P.O. Box 26671, Bahrain. Hauptthemen laut MEDLINE: Warfarin, Cytochrome P-450 CYP2C9, Vitamin K Epoxide Reductases, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AGU RCSI-MUB Joint research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Warfarin pharmacogenomics is critical due to its narrow therapeutic index and significant interpatient variability. While machine learning (ML) can predict anticoagulation control status (ACS), its “black-box” nature limits clinical translatability. Explainable Artificial Intelligence (XAI) addresses this by providing interpretable insights. This study applied ML and XAI to a warfarin pharmacogenomic dataset to predict poor ACS and explain model decisions.

Methods

A post hoc analysis was conducted on a cross-sectional dataset of 232 patients receiving warfarin for ≥6 months. Data included age, gender, interacting drugs, SAMe-TT2R2 score, and genotypes for CYP2C9, VKORC1, and CYP4F2. Poor ACS was defined as time in therapeutic range (TTR) < 70%. The dataset was split into training (70%) and testing (30%) cohorts. Three models, Random Forest, XGBoost, and Logistic Regression, were developed and evaluated using AUC-ROC, sensitivity, and specificity. XAI techniques, including permutation importance and SHapley Additive exPlanations (SHAP), were employed for global and local interpretability.

Results

Of 232 patients, 141 (60.8%) had poor ACS. XGBoost and Random Forest demonstrated comparable predictive accuracy (AUC-ROC: 0.67), outperforming Logistic Regression. Sensitivity was 0.83 and 0.79 for XGBoost and Random Forest, respectively. However, specificity was modest for both ensemble methods (Random Forest: 0.48; XGBoost: 0.41) and extremely low for Logistic Regression (0.04), indicating poor discrimination, particularly for identifying patients with adequate anticoagulation control. Globally, important predictors included the age, SAMe-TT2R2 score, CYP2C9 (*2/*2), female gender, and VKORC1 (C/T). XAI revealed predictions were primarily driven by VKORC1, CYP4F2, SAMe-TT2R2 scores, and drug interactions. Concordance between XAI predictions and actual ACS was 78% for adequate and 88.6% for poor ACS. SHAP analysis showed VKORC1 provided a stable risk signal (mean absolute SHAP: 1.44 ± 0.49 in concordant cases), while CYP2C9 was a high-variance, high-impact driver of discordance (mean SHAP: 3.44 ± 3.79 in discordant cases).

Conclusions

ML models, particularly ensemble methods, show modest ability to predict poor warfarin control with limited ability to correctly identify patients with adequate control from our dataset. XAI transforms these models into interpretable tools, with SHAP analysis attributing predictions to specific genetic and clinical features. While predictive accuracy remains modest, this approach enhances transparency and provides a foundation for generating hypotheses that may ultimately support clinical decision-making in pharmacogenomic-guided warfarin therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WarfarinCytochrome P-450 CYP2C9Vitamin K Epoxide ReductasesAnticoagulantsArtificial IntelligenceHumansFemaleMaleCross-Sectional StudiesRandom ForestAgedBoosting Machine Learning AlgorithmsMiddle AgedPharmacogeneticsPrediction AlgorithmsPredictive Learning Models

Stichwörter der Autor:innen

XAIartificial intelligencepersonalized therapywarfarin

Substanzen

WarfarinCytochrome P-450 CYP2C9Vitamin K Epoxide ReductasesAnticoagulantsVKORC1 protein, humanCYP2C9 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, Arabian Gulf University, Manama P.O. Box 26671, Bahrain.
  • Bahrain Defence Force Royal Medical Services, Riffa P.O. Box 28743, Bahrain.

ORCID-Profile: Kannan Sridharan, Gowri Sivaramakrishnan

Förderung

  • AGU RCSI-MUB Joint research

Zitieren

APA

Sridharan, K., & Sivaramakrishnan, G. (2026). Explainable Artificial Intelligence Unravels the Possible Distinct Roles of VKORC1 and CYP2C9 in Predicting Warfarin Anticoagulation Control. Medical Sciences. https://doi.org/10.3390/medsci14010156

Vancouver

Sridharan K, Sivaramakrishnan G. Explainable Artificial Intelligence Unravels the Possible Distinct Roles of VKORC1 and CYP2C9 in Predicting Warfarin Anticoagulation Control. Medical Sciences. 2026. doi:10.3390/medsci14010156

BibTeX
@article{Sridharan2026,
  author = {Sridharan, Kannan and Sivaramakrishnan, Gowri},
  title = {Explainable Artificial Intelligence Unravels the Possible Distinct Roles of VKORC1 and CYP2C9 in Predicting Warfarin Anticoagulation Control},
  journal = {Medical Sciences},
  year = {2026},
  doi = {10.3390/medsci14010156}
}
Kostenlos starten →